Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema
- 15 September 2005
- journal article
- clinical trial
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 172 (6) , 763-767
- https://doi.org/10.1164/rccm.200504-654oc
Abstract
High-altitude pulmonary edema (HAPE) is characterized by excessive pulmonary vasoconstriction and is associated with decreased concentrations of nitric oxide (NO) in the lung. We hypothesized that individuals susceptible to HAPE (HAPE-S) would also have dysfunction of the vascular NO vasodilator pathway during hypoxia in the systemic vasculature. During normoxia (FI(O(2)) = 0.21) and 4 hours of normobaric hypoxia (FI(O(2)) = 0.12, corresponding to an altitude of 4,500 m above sea level) endothelium-dependent and endothelium-independent vasodilator responses to intraarterial infusion of acetylcholine (ACh) and sodium nitroprusside, respectively, were measured by forearm venous occlusion plethysmography in nine HAPE-S subjects and in nine HAPE-resistant control subjects. Pulmonary artery systolic pressure increased from 22 +/- 3 to 33 +/- 6 mm Hg (p < 0.001) during hypoxia in control subjects, and from 25 +/- 4 to 50 +/- 9 mm Hg in HAPE-S subjects (p < 0.001). Despite similar responses during normoxia in both groups, ACh-induced changes in forearm blood flow markedly decreased during hypoxia in HAPE-S subjects (p = 0.01) but not in control subjects. The attenuated vascular response to ACh infusion during hypoxia inversely correlated with increased pulmonary artery systolic pressure (p = 0.04) and decreased plasma nitrite correlated with attenuated ACh-induced vasodilation in HAPE-S subjects (p = 0.02). Hypoxia markedly impairs vascular endothelial function in the systemic circulation in HAPE-S subjects due to a decreased bioavailability of NO. Impairment of the NO pathway could contribute to the enhanced hypoxic pulmonary vasoconstriction that is central to the pathogenesis of HAPE.Keywords
This publication has 29 references indexed in Scilit:
- Pulmonary Blood Flow Heterogeneity during Hypoxia and High-Altitude Pulmonary EdemaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2003
- Pathogenesis of High-Altitude Pulmonary EdemaJAMA, 2002
- High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary PressureCirculation, 2001
- Hypoxia Decreases Exhaled Nitric Oxide in Mountaineers Susceptible to High-Altitude Pulmonary EdemaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Exhaled Nitric Oxide in High-Altitude Pulmonary EdemaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- High Altitude Pulmonary EdemaRespiration, 1997
- Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humansJournal of the American College of Cardiology, 1996
- Inhaled Nitric Oxide for High-Altitude Pulmonary EdemaNew England Journal of Medicine, 1996
- Prevention of High-Altitude Pulmonary Edema by NifedipineNew England Journal of Medicine, 1991